An Open-label, Non-comparative Study to Document the Tolerability to Ramipril in Patients With at Least One High Risk for Developing a Major Cardiovascular Event

PHASE4CompletedINTERVENTIONAL

Enrollment

179

Participants

Timeline

Start Date

November 1, 2008

Primary Completion Date

April 23, 2010

Study Completion Date

April 23, 2010

Conditions

Coronary Artery Disease

Interventions

DRUG

RAMIPRIL HOE498

Pharmaceutical form:Tablet Route of administration: Oral

Trial Locations (1)

Sanofi Administrative Office, Bali